NCT01020253

The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)

A Comparison of Alendronate vs. Alfacalcidol Medication for the Preservation of Bone Mineral Density Around the Femoral Implant and in the Lumbar Spine After a Total Hip Arthroplasty

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Yokohama City University Medical Center · Academic / Other
• Sex: All
• Age: 44 Years – 82 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate whether alendronate and alfacalcidol are effective on prosthetic or lumbar spine BMD after total hip arthroplasty.

Conditions

• Bone Density
• Arthroplasty, Replacement, Hip

Interventions

Type	Name	Description
DRUG	alendronate, alfacalcidol	Alendronate: 5mg per day, Tablet, Duration is 48 weeks. Alfacalcidol: 1μg per day, Tablet, Duration is 48 weeks.

Timeline

• Start date: 2006-01-01
• Primary completion: 2008-04-01
• First posted: 2009-11-25
• Last updated: 2009-12-03

Locations

1 site across 1 country: Japan